George A. Eldridge - Nov 18, 2022 Form 4 Insider Report for Aerovate Therapeutics, Inc. (AVTE)

Role
Officer Title: Chief Financial Officer and Treasurer
Signature
/s/ George A. Eldridge
Stock symbol
AVTE
Transactions as of
Nov 18, 2022
Transactions value $
-$17,932
Form type
4
Date filed
11/22/2022, 07:00 PM
Previous filing
Dec 16, 2021
Next filing
Nov 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTE Common Stock Options Exercise $1.84K +861 +43.93% $2.14* 2.82K Nov 18, 2022 Direct F1, F2
transaction AVTE Common Stock Sale -$15.2K -780 -27.65% $19.45 2.04K Nov 18, 2022 Direct F1, F3
transaction AVTE Common Stock Sale -$1.63K -81 -3.97% $20.13 1.96K Nov 18, 2022 Direct F1, F4
transaction AVTE Common Stock Options Exercise $4.28 +2 +0.1% $2.14* 1.96K Nov 21, 2022 Direct F1
transaction AVTE Common Stock Sale -$38 -2 -0.1% $19.00 1.96K Nov 21, 2022 Direct F1
transaction AVTE Common Stock Options Exercise $372 +174 +8.88% $2.14* 2.13K Nov 22, 2022 Direct F1
transaction AVTE Common Stock Sale -$3.31K -174 -8.15% $19.01 1.96K Nov 22, 2022 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -861 -0.87% $0.00 97.8K Nov 18, 2022 Common Stock 861 $2.14 Direct F1, F6
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -2 0% $0.00 97.8K Nov 21, 2022 Common Stock 2 $2.14 Direct F1, F6
transaction AVTE Stock Option (Right to Buy) Options Exercise $0 -174 -0.18% $0.00 97.6K Nov 22, 2022 Common Stock 174 $2.14 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.
F2 Includes 1,960 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d).
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.06 to $20.045, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.095 to $20.29, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.03, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F6 A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Remarks:

Officer Title: Chief Financial Officer and Treasurer